Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Drug Development
Revvity Omics: expertise in drug development, from inception to market.
March 25, 2024 -
3 min read
Drug Development
An overview of RAS protein mutations in cancer and KRAS-targeted therapeutics.
March 15, 2024 -
4 min read
